Related Experiment Video
Updated: Jul 6, 2026
Murine Left Pulmonary Hilar Clamp Model of Lung Ischemia Reperfusion Injury
Published on: April 12, 2024
Stress-activated protein kinase inhibition to ameliorate lung ischemia reperfusion injury
Patrick S Wolf1, Heather E Merry, Alexander S Farivar
1Division of Thoracic Surgery, University of Washington, Seattle, Wash, USA.
Objective:
Inhibition of cytokines offers modest protection from injury in animal models of lung ischemia-reperfusion. Improved strategies would selectively inhibit the transcriptional activation response to oxidative stress. Mitogen-activated protein kinases (p38, c-jun N-terminal kinase, extracellular signal-regulated kinase) have been shown to be activated after oxidative stress and in animal models of acute inflammatory lung injury. We hypothesized that mitogen-activated protein kinase inhibition would block downstream transcriptional activation, providing robust protection from lung ischemia-reperfusion injury.
Methods:
Experimental rats received inhibitors of p38, c-jun kinase, or extracellular signal-regulated kinase before in situ left lung ischemia-reperfusion. Immunohistochemistry localized cellular sites of mitogen-activated protein kinase activation. Several markers of lung injury were assessed. Enzyme-linked immunosorbent assay measured soluble cytokine and chemokine contents. Western blotting assessed mitogen-activated protein kinase phosphorylation. Electromobility shift assays measured transcription factor nuclear translocation.
Results:
Immunohistochemistry localized p38 and c-jun kinase activations in positive controls to alveolar macrophages. Extracellular signal-regulated kinase was activated in endothelial and epithelial cells. Animals treated with p38 or c-jun kinase inhibitor demonstrated significant reductions in transcription factor activation and markers of lung injury. Extracellular signal-regulated kinase inhibition was not protective. Western blotting confirmed inhibitor specificity.
Conclusion:
Inhibition of p38 and c-jun kinase provided significant protection from injury. The alveolar macrophage appears to be the key coordinator of injury in response to oxidative stress. Therapeutically targeting specific cell population (macrophage) responses to oxidative stress has the potential benefit of reducing lung reperfusion injury severity while leaving host immune responses intact.
Insights
Inhibiting p38 and c-jun kinase in rats significantly reduced lung injury markers after ischemia-reperfusion. Targeting alveolar macrophages offers a promising strategy for mitigating lung reperfusion injury.
Area of Science:
- Biomedical Science
- Molecular Biology
- Immunology
Background:
- Cytokine inhibition provides limited protection against lung ischemia-reperfusion injury.
- Mitogen-activated protein kinases (MAPKs) are activated by oxidative stress and implicated in inflammatory lung injury.
- Targeting MAPK-mediated transcriptional activation may offer improved protection.
Purpose of the Study:
- To investigate the protective effects of inhibiting specific MAPKs (p38, c-jun kinase, extracellular signal-regulated kinase) against lung ischemia-reperfusion injury.
- To determine if MAPK inhibition blocks downstream transcriptional activation and reduces lung injury.
- To identify the key cellular targets of MAPK activation in this injury model.
Main Methods:
- Rats were treated with specific MAPK inhibitors before inducing lung ischemia-reperfusion.
- Immunohistochemistry was used to localize MAPK activation.
- Markers of lung injury, cytokine/chemokine levels, and transcription factor activation were assessed.
Main Results:
- p38 and c-jun kinase inhibition significantly reduced lung injury and transcription factor activation.
- Extracellular signal-regulated kinase inhibition did not provide protection.
- MAPK activation was localized to alveolar macrophages (p38, c-jun kinase) and endothelial/epithelial cells (ERK).
Conclusions:
- Inhibition of p38 and c-jun kinase offers significant protection against lung ischemia-reperfusion injury.
- Alveolar macrophages are identified as key mediators of injury in response to oxidative stress.
- Targeting macrophage responses to oxidative stress presents a potential therapeutic strategy to reduce lung reperfusion injury severity while preserving host immunity.
